WO2012055582A2 - Hair treatment products containing 3-methyl-1,3-butanediol and amphoteric surfactant(s) - Google Patents

Abstract

Hair cleaning products which have increased hair care effect and particularly improve softness, suppleness and shine of the hair contain, based on their weight, 0.01 to 40% of weight of 3-methyl-1,3-butanediol and 0.1 to 20% by weight of amphoteric surfactant(s).

Description

 "Hair treatment compositions containing 3-methyl-1, 3-butanediol and amphoteric surfactant (s)"

 The present invention relates to hair treatment compositions which cause special care effects.

Human hair is today treated in a variety of ways with hair cosmetic preparations. These include, for example, the cleansing of hair with shampoos, the care and regeneration with rinses and cures and the bleaching, dyeing and shaping of the hair with dyes, tinting agents, waving agents and styling preparations. Not least by the heavy use of hair, for example by dyeing or perming as well as by the hair with shampoos and by environmental pollution, the importance of care products with the longest possible effect increases. Such care products affect the natural structure and properties of the hair. Thus, for example, the wet and dry combability of the hair, the hold and the fullness of the hair can be optimized or the hair can be protected from increased splits following such treatments.

 It has therefore long been customary to subject the hair to a special aftertreatment. In this case, the hair is treated with special active ingredients, for example quaternary ammonium salts or special polymers, usually in the form of a rinse. Depending on the formulation, this treatment improves the combability, the hold and the fullness of the hair and reduces the splitting rate.

 Furthermore, so-called combination preparations have recently been developed to reduce the burden of the usual multi-stage process, especially in the direct application by consumers. The available active ingredients both for separate aftertreatment agents and for combination preparations generally have a preferential effect on the hair surface. Thus, active ingredients are known which give the hair shine, hold, fullness, better wet or dry combabilities or prevent splitting. Just as important as the external appearance of the hair, however, is the internal structural cohesion of the hair fibers, which can be greatly influenced, in particular, by oxidative and reductive processes such as dyeing and perming.

However, the known active ingredients can not cover all needs sufficiently. Particularly in the case of hair cleansing, an increased awareness of hygiene leads to an ever more frequent cleaning of the hair. In order to be here in addition to optimal cleaning and hair care long-term, the funds used must be particularly mild to the hair and scalp. There is therefore still a need for active ingredients or combinations of active ingredients for hair treatment compositions which not only do not have the properties of the fibers treated with them but improve on the contrary. In addition, the new ingredients should also be compatible with a broad range of other common ingredients and, at best, even more effective.

 It is an object of the present invention to provide hair-treatment compositions, in particular hair-cleansing compositions, which have an enhanced hair-care effect. In particular, softness, suppleness and shine of the hair should be improved by the use of the agents.

 It has now been found that a special combination of isopentyl diol with surfactant (s) gives hair treatment agents a special care effect.

 The present invention relates to hair treatment compositions containing - based on their weight - a) 0.01 to 40 wt .-% of 3-methyl-1, 3-butanediol,

 b) 0.1 to 20% by weight of amphoteric surfactant (s).

 Hair treatment compositions for the purposes of the present invention are, for example, hair shampoos, hair conditioners, conditioning shampoos, hairsprays, hair conditioners, hair treatments, hair wraps, hair tonics, perming solutions, hair dye shampoos, hair dyes, hair fixatives, hair dressings, hairstyling preparations, hair lotions, mousses, hair gels , Hair waxes or their combinations. Preferred agents according to the invention are shampoos, conditioners or hair tonics, in particular shampoos.

The agents according to the invention contain as the first essential ingredient - based on their weight - 0 01 to 40 wt .-% 3-methyl-1, 3-butanediol:

 This substance, also referred to as isopentyl diol, has nourishing and moisturizing properties and, in combination with surfactant (s), leads to improved softness and suppleness of the hair. In addition, the gloss of the fibers is significantly intensified.

Very particular preference is given to using 3-methyl-1,3-butanediol in the compositions according to the invention within narrower ranges of amounts. Hair-treatment compositions according to the invention are preferred here which, based on their weight, contain 0.05 to 30% by weight, preferably 0.1 to 20% by weight and in particular 0.25 to 10% by weight of 3-methyl-1, 3-butanediol included.

 As a second essential ingredient, the compositions according to the invention contain from 0.1 to 20% by weight of amphoteric surfactant (s). Amphoteric surfactants can be subdivided into zwitterionic and ampholytic surfactants.

Zwitterionic surfactants and emulsifiers are surface-active compounds which contain at least one quaternary ammonium group and at least one in the molecule - carry or -S0 ₃ ^<_) group - COO ^<_). Particularly suitable zwitterionic surfactants and Emulsifiers are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl N, N-dimethylammonium glycinates, for example cocoacylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxymethyl-3-ol Hydroxyethylimidazoline each having 8 to 18 carbon atoms in the alkyl or acyl group and Kokosacylaminoethylhydroxyethylcarboxymethylglycinat. A preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.

Ampholytic surfactants and emulsifiers are surface-active compounds which, apart from a C ₈ - contain at least one free amino group and at least one -COOH or -S0 ₃ H group and alkyl or acyl group capable of forming inner salts - C ₂ 4 are. Examples of suitable ampholytic surfactants are N-alkylglycines, N-alkylaminopropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C atoms in the alkyl group. Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and the d ₂ -C ₈ -acylsarcosine.

Particularly preferred hair treatment compositions according to the invention are characterized in that they contain amphoteric surfactant (s) from the groups of N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids containing around 8 to 24 carbon atoms in the alkyl group, alkyl aminoacetic acids containing around 8 to 24 carbon atoms in the alkyl group, N-cocoalkylaminopropionate, cocoacylaminoethyl aminopropionate C ₁₂ - C ₈ - acyl sarcosine, N-alkyl - Ν, Ν-dimethylammonium glycinates, for example, cocoalkyl dimethylammoniumglycinat, N-acylaminopropyl-N, N-dimethylammoniumglycinate, for example Kokosacylaminopropyl- dimethylammoniumglycinat, 2-alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 C. -Atomen in the alkyl or acyl group Kokosacylaminoethylhydroxyethylcarboxymethyl- glycinate, the beka under the INCI name Cocamidopropyl betaine beka compounds containing the compounds known under the INCI name Disodium Cocoamphodiacetate, preferred agents comprising the amphoteric surfactant (s) in amounts of from 0.5 to 9% by weight, preferably from 0.75 to 8 Wt .-% and in particular from 1 to 7.5 wt .-%, each based on the total agent included.

 Particularly preferred hair treatment compositions contain as amphoteric surfactants betaines of the formula (VI)

in which R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms. These surfactants are referred to the INCI nomenclature as Amidopropylbetaine, wherein the representatives derived from coconut fatty acids are preferred and are referred to as Cocoamidopropylbetaine. According to the invention, particular preference is given to using surfactants of the formula (II) which are a mixture of the following representatives: H ₃ C- (CH ₂ ) ₇ -C (O) -NH- (CH ₂ ) ₃ N ⁺ (CH ₃ ) ₂ CH ₂ COO ^~, H ₃ C- (CH _{2) 9} -C (0) -NH- (CH _{2) 3} N ⁺ (CH _{3) 2} CH ₂ COO ^~, H ₃ C- (CH _{2) 11} -C ( 0) -NH- (CH _{2) 3} N ⁺ (CH _{3) 2} CH ₂ COO ^~, H ₃ C- (CH _{2) 13} -C (0) -NH- (CH _{2) 3} N ⁺ (CH _{3) 2} CH ₂ COO ^"H ₃ C- (CH _{2) 15} -C (0) -NH- (CH _{2) 3} N ⁺ (CH _{3) 2} CH ₂ COO ^~, H ₃ C- (CH _{2) 7} - CH = CH- (CH ₂ ) ₇ -C (O) -NH- (CH ₂ ) ₃ N ⁺ (CH ₃ ) ₂ CH ₂ COO ^"

Particular preference is given to using surfactants of the formula (VI) within narrower ranges of amounts. Here, agents according to the invention are preferred which, based on their weight, are from 0.25 to 8% by weight, more preferably from 0.5 to 7% by weight, more preferably from 0.75 to 6.5% by weight and in particular 1 to 5.5 wt .-% of surfactant (s) of the formula (VI).

 In addition to the amphoteric surfactant (s) of the formula (VI) or in its place, the hair-treatment compositions according to the invention may be used with particular preference as amphoteric surfactants betaines of the formula (VII)

in which R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms.

 These surfactants are referred to according to the INCI nomenclature as amphoacetates, wherein the representatives derived from coconut fatty acids are preferred and are referred to as cocoamphoactetates.

 For reasons of production technology, surfactants of this type always also contain betaines of the formula (VIIa)

in which R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms and M is a cation. These surfactants are referred to according to the INCI nomenclature as Amphodiacetate, wherein the representatives derived from coconut fatty acids are preferred and are referred to as Cocoamphodiactetate. According to the invention, particular preference is given to using surfactants of the formula (VII) which are a mixture of the following representatives: H ₃ C- (CH 2) 7-C (O) -NH- (CH ₂ ) ₂ NH ⁺ (CH ₂ CH ₂ OH) CH ₂ CH ₂ COO ^- H ₃ C- (CH2) 9-C (0) -NH- (CH2) 2 NH ⁺ (CH 2 CH ₂ OH) CH2CH2COO ^", H ₃ C- (CH ₂₎ n C (0) -NH- (CH ₂₎ 2 NH ⁺ (CH 2 CH ₂ OH ) CH2CH2COO ^", H ₃ C- (CH 2) ₁₃ -C (0) -NH- (CH2) 2 NH ⁺ (CH 2 CH ₂ OH) CH2CH2COO ^~ H3C- (CH2) ₁₅ -C (0) -NH- (CH2) 2NH ⁺ (CH2CH20H) CH2CH2COO ^", H ₃ C- (CH ₂₎ 7 -CH = CH- _(CH2) 7-C (0) -NH- (CH2) 2NH ⁺ (CH2CH20H) CH 2 CH ₂ ^COO" particularly preferred are Surfactants of the formula (VII) used within narrower ranges. Here, agents according to the invention are preferred which, based on their weight, are from 0.25 to 8% by weight, more preferably from 0.5 to 7% by weight, more preferably from 0.75 to 6.5% by weight and in particular 1 to 5.5 wt .-% of surfactant (s) of the formula (VII). In summary, hair treatment agents according to the invention are preferred in which the radical R in the formulas (VI) and (VII) is selected from H ₃ C- (CH ₂ ) ₇ -, H ₃ C- (CH ₂ ) _9- , H ₃ C- (CH ₂ ) n-, H ₃ C- (CH ₂ ) i3-, H ₃ C- (CH ₂ ) i5-, H ₃ C- (CH ₂ ) 7 -CH = CH- (CH ₂ ) 7- or Mixtures of these.

The compositions according to the invention may contain, in addition to the ampholytic surfactants, further surfactants.

 Suitable anionic surfactants and emulsifiers for the compositions according to the invention are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. As a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups as well as hydroxyl groups may be present in the molecule. Examples of suitable anionic surfactants and emulsifiers are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts having 2 to 4 C atoms in the alkanol group,

 linear and branched fatty acids with 8 to 30 carbon atoms (soaps),

Ether carboxylic acids of the formula R-O- (CH ₂ -CH ₂ O) _x -CH ₂ -COOH, in which R is a linear alkyl group having 8 to 30 C atoms and x = 0 or 1 to 16,

 Acylsarcosides having 8 to 24 carbon atoms in the acyl group,

 Acyltaurides having 8 to 24 carbon atoms in the acyl group,

 Acyl isethionates having 8 to 24 carbon atoms in the acyl group,

 linear alkanesulfonates having 8 to 24 C atoms,

 linear alpha-olefin sulfonates having 8 to 24 C atoms,

 Alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 carbon atoms,

 Acylglutamates of the formula (I),

XOOC-CH ₂ CH ₂ CH-COOX (I)

 I

HN-COR

in which R CO is a linear or branched acyl radical having 6 to 22 carbon atoms and 0, 1, 2 or 3 double bonds and X is hydrogen, an alkali and / or alkaline earth metal, ammonium, alkylammonium, alkanolammonium or glucammonium, for example Acyl glutamates, which are derived from fatty acids having 6 to 22, preferably 12 to 18 carbon atoms, such as C ₁₂ / 14- or Ci ₂ / i8-coconut fatty acid, lauric acid, myristic acid, palmitic acid and / or stearic acid, particularly sodium N-cocoyl and sodium N-stearoyl-L-glutamate,

 Esters of a hydroxy-substituted di- or tricarboxylic acid of the general formula (II),

 X

I

HO- COOR (II)

 I

Y is CHCOOR ² wherein X is H or a -CH ₂ COOR group, Y is H or -OH is under the condition that Y is H when X is -CH ₂ COOR, R, R and R ² independently of one another denote a hydrogen atom, an alkali metal or alkaline earth metal cation, an ammonium group which is a cation of an ammonium organic base or a Z radical derived from a polyhydroxylated organic compound selected from the group of etherified (C ₆ -C ₁₈ ) Alkylpolysaccharides having from 1 to 6 monomeric saccharide units and / or the etherified aliphatic (C ₆ -C ₁₆ ) -hydroxyalkylpolyols having from 2 to 16 hydroxyl radicals, provided that at least one of the groups R, R or R ^{2 is} a radical Z,

 Esters of sulfosuccinic acid or sulfosuccinates of general formula (III),

H ₂ C-COOR ¹ (III)

 I

_M (n ₊ / n) - ₀₃ g _ Q _H _ COOR ² in the M ^{(n + / n)} for n = 1, a hydrogen atom, an alkali metal cation, an ammonium group or the cation of an ammonium organic base and for n = 2 Represents alkaline earth metal cation and R and R ^{2 are} independently a hydrogen atom, an alkali or alkaline earth metal cation, an ammonium group, the cation of an ammonium organic base or a radical Z derived from a polyhydroxylated organic compound selected from the group of etherified (C ₆ -C ₈₎ -Alkylpolysaccharide having 1 to 6 monomeric saccharide units and / or etherified aliphatic (C ₆ -C ₆₎ -hydroxyalkylpolyols is selected having 2 to 16 hydroxyl radicals, among the proviso that at least one of the groups R or R ² Rest Z is,

Sulfosuccinic acid mono- and dialkyl esters having 8 to 24 C atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethyl esters having 8 to 24 C atoms in the alkyl group and 1 to 6 oxyethyl groups, Alkyl sulfates and alkyl polyglycol ether sulfates of the formula R- (O-CH ₂ -CH ₂ ) x -OSO ₃ H, in which R is a preferably linear alkyl group having 8 to 30 C atoms and x = 0 or 1 - 12,

 mixed surface-active hydroxysulfonates according to DE-A-37 25 030,

Esters of tartaric acid and citric acid with alcohols which are addition products of approximately 2-15 molecules of ethylene oxide and / or propylene oxide with C ₈ -22 fatty alcohols represent

 Alkyl and / or alkenyl ether phosphates,

 sulfated fatty acid alkylene glycol esters,

 Monoglyceride sulfates and monoglyceride ether sulfates.

Preferred anionic surfactants and emulsifiers are acylglutamates, acyl isethionates, acyl sarcosinates and acyl taurates, each with a linear or branched acyl radical having 6 to 22 carbon atoms and 0, 1, 2 or 3 double bonds, which in particularly preferred embodiments of an octanoyl, decanoyl, lauroyl , Myristoyl, palmitoyl and stearoyl radical, esters of tartaric acid, citric acid or succinic acid or of the salts of these acids with alkylated glucose, in particular the products with the INCI name Disodium Coco-Glucoside Citrate, Sodium Coco-Glucoside Tartrate and Disodium Coco-glucosides sulfosuccinates, alkyl polyglycol ether sulfates and ether carboxylic acids having 8 to 18 carbon atoms in the alkyl group and up to 12 ethoxy groups in the molecule, sulfosuccinic acid mono- and dialkyl esters having 8 to 18 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethyl ester having 8 to 18 carbon atoms in the alkyl group and 1 to 6 ethoxy groups.

 Further preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acid salts having 10 to 18 C atoms in the alkyl group and up to 12 glycol ether groups in the molecule and sulfosuccinic acid mono- and dialkyl esters having 8 to 18 C atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethylester with 8 to 18 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups.

 Particularly preferred anionic surfactants are the alkali metal or ammonium salts of lauryl ether sulfate having a degree of ethoxylation of 2 to 4 EO.

 Particularly preferred hair treatment compositions according to the invention are characterized in that they contain - based on their weight - 0.1 to 20 wt .-%, preferably 0.25 to 17.5 wt .-% and in particular 5 to 15 wt .-% of anionic (s ) Surfactant (s), more preferably fatty alcohol ether sulfates of the formula

H ₃ C- (CH 2) n - (OCH 2 CH 2) _k -OSO 3 ^" M ⁺

in which n represents values of from 5 to 21, preferably from 7 to 19, particularly preferably from 9 to 17 and in particular from 1 to 13 and k for values of 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10, preferably 1, 2 or 3 and especially 2, and M is a cation from the group Na ⁺ , K ⁺ NH ₄ ⁺ , Mg ²⁺ , Zn ²⁺ , preferably Na ⁺ ,

Particularly preferred nonionic surfactants are alkyl polyglycosides. Alkylpolyglycosides (APG) are non-ionic surfactants that are produced entirely from renewable raw materials (sugar components, predominantly glucose, for example from corn starch and fatty alcohol, for example from coconut oil). Alkyl polyglycosides are accessible by acid-catalyzed reaction (Fischer reaction) of sugars, especially glucose (or starch) or butyl glycosides with fatty alcohols.

Complex mixtures of alkyl monoglucoside (alkyl-α-D- and β-D-glucopyranoside and small amounts of glucofuranoside), alkyldiglucosides (-isomaltosides, maltosides, etc.) and alkyl oligoglucosides (maltotriosides, tetraosides, etc.) are formed. The average degree of polymerization of commercial products whose alkyl radicals are in the range C8-C16 is 1, 2-1, 5.

According to the invention, preference is given to using alkylpolyglycosides corresponding to the general formula RO - (Z) _x , where R is alkyl, Z is sugar and x is the number of sugar units. Particular preference is given to those alkylpolyglycosides in which R

essentially C ₈ and C ₁₀ alkyl groups,

essentially from d ₂ - and C- | _4- alkyl groups,

essentially from C ₈ - to C- | ₆ alkyl groups or

essentially from Ci ₂ - to C- | ₆ alkyl groups or

essentially from d ₆ to C- | ₈ alkyl groups

consists.

 As sugar building block Z it is possible to use any desired mono- or oligosaccharides. Usually, sugars with 5 or 6 carbon atoms and the corresponding oligosaccharides are used. Such sugars are, for example, glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, idose, talose and sucrose. Preferred sugar building blocks are glucose, fructose, galactose, arabinose and sucrose. Accordingly, preferred hair treatment compositions according to the invention are characterized in that they - based on their weight - 0, 1 to 20 wt .-%, preferably 1 to 10 wt .-% and in particular 2 to 8 wt .-% alkylpolyglycoside (e) of the formula

H ₃ C- (CH ₂ ) _n -O- (Z) _x

in which n is from 5 to 21, preferably from 7 to 19, more preferably from 9 to 17 and especially from 1 to 13, and k is from 1 to 1 to 8, preferably from 1 to 2 1, 5, and Z stands for a sugar unit from the group glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, idose, talose and sucrose.

 Glucose is a particularly preferred sugar building block (Z), so that preferred hair treatment compositions according to the invention are characterized in that they are based on their weight - 0.1 to 15 wt .-%, preferably 1 to 10 wt .-% and in particular 2 to 8 Wt .-% Alkylpolyglucosid (e) of the formula

in which n is from 5 to 21, preferably from 7 to 19, more preferably from 9 to 17 and especially from 1 to 13, and m is from 1 to 1 to 8, preferably from 1 to 2 1, 5 stand.

 The alkylpolyglycosides which can be used according to the invention contain on average 1, 1 to 5 sugar units. Alkyl polyglycosides having x values of 1.1 to 2.0 are preferred. Very particular preference is given to alkyl glycosides in which x is 1: 1 to 1, 8.

 Very particularly preferred alkyl polyglucosides are those whose alkyl radical is a lauryl radical. For mixtures of substances from natural sources, preference is given to those sources which have a high proportion of C 12 fatty acids, in particular coconut fatty acids. Accordingly, particularly preferred hair treatment compositions according to the invention are characterized in that they are based on their weight - 0.1 to 15 wt .-%, preferably 1 to 10 wt .-% and in particular 2 to 8 wt .-% Alkylpolyglucosid (e) of the formula

in which n stands for the value 1 1 m for values of 1, 1 to 1, 8, preferably from 1, 2 to 1, 5 stand.

 Also usable according to the invention are cationic surfactants of the quaternary ammonium compound type, the esterquats and the amidoamines. Preferred quaternary ammonium compounds are ammonium halides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides. The long alkyl chains of these surfactants preferably have 10 to 18 carbon atoms, such as. In cetyl trimethyl ammonium chloride, stearyl trimethyl ammonium chloride, distearyl dimethyl ammonium chloride, lauryl dimethyl ammonium chloride, lauryl dimethyl benzyl ammonium chloride and tricetylmethyl ammonium chloride. Further preferred cationic surfactants are the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83.

 The care effects of the compositions according to the invention can be further enhanced by using certain care substances. These are preferably selected from certain groups of known care substances, since these care substances perfectly harmonize with the combination according to the invention in terms of formulation and the care effect.

Hair treatment compositions which are preferred according to the invention are characterized in that they additionally have care substance (s), based on their weight, in amounts of from 0.001 to 10% by weight, preferably from 0.005 to 7.5% by weight, particularly preferably from 0.01 to 5 Wt .-% and in particular 0.05 to 2.5 wt .-%, with preferred care substance (s) are selected from the group

 L-carnitine and / or its salts;

 Panthenol and / or panthothenic acid;

III of 2-furanones and / or their derivatives, in particular pantolactone; Taurine and / or its salts;

 niacinamide;

 ubiquinone

 Ectoin;

 Allantoin.

 In hair treatment compositions of this embodiment according to the invention, the 3-methyl-1,3-butanediol / surfactant combination is combined with at least one conditioner selected from L-carnitine and / or its salts, panthenol and / or pantothenic acid, 2-furanones and / or their derivatives, in particular pantolactone, taurine and / or its salts, niacinamide, ubiquinones, ectoine, allantoin. These conditioners are described below

L-carnitine (IUPAC name (R) - (3-carboxy-2-hydroxypropyl) -A /, A /, A / -trimethylammonium hydroxide) is a naturally occurring, vitamin-like substance.

 As betaine, L-carnitine can form addition compounds and double salts. L-carnitine derivatives which are preferred according to the invention are selected in particular from acetyl-L-carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl-L-carnitine and particularly preferably L-carnitine tartrate.

Preferred hair treatment compositions according to the invention are characterized in that they contain -0.001 to 10% by weight, preferably 0.005 to 7.5% by weight, particularly preferably 0.01 to 5% by weight, and in particular 0.05, by weight contain up to 2.5 wt .-% L-carnitine or L-carnitine derivatives, preferred L-carnitine derivatives are selected from acetyl-L-carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl-L-carnitine and in particular L-carnitine tartrate. Panthenol (IUPAC name: (+) - (R) -2,4-dihydroxy-N- (3-hydroxypropyl) -3,3-dimethylbutyramide) is converted to pantothenic acid in the body. Pantothenic acid is a vitamin from the group of B vitamins (vitamin B5). Preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.01 to 5% by weight, preferably from 0.05 to 2.5% by weight, more preferably from 0.1 to 1.5% by weight. % and especially 0.25 to 1% by weight of panthenol ((±) -2,4-dihydroxy-A / - (3-hydroxypropyl) -3,3-dimethylbutyramide).

 According to the invention preferred hair treatment compositions contain - based on their weight - 0.01 to 15 wt .-%, preferably 0.025 to 12.5 wt .-%, particularly preferably 0.05 to 10 wt .-%, more preferably 0, 1 to 7 , 5% by weight and in particular 0.5 to 5% by weight of at least one 2-furanone derivative of the formula (Fur-I) and / or of the formula (Fur-II)

in which the radicals R to R ^{0 are} independently of one another

Hydrogen, -OH, a methyl, methoxy, aminomethyl or hydroxymethyl radical, --C ₂ - C ₄ - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical,

--C ₂ - C ₄ - saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,

--C ₂ - C ₄ - saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,

a group -OR, with R as a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono- , Di- or trihydroxyhydrocarbyl radical,

- a group -NR ² R ¹³ , wherein R ² and R ³ each independently represent hydrogen, a methyl, a C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,

a group -COOR ⁴ , where R ⁴ is hydrogen, a methyl, a C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ -saturated hydrocarbon radical, or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbon hydrocarbon radical, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbyl radical,

a group -CONR ⁵ R ¹⁶ , wherein R ⁵ and R ⁶ each represent hydrogen, methyl, a -C ₂

- C ₄ - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ - C ₄ - saturated mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical, a -C ₂ - C ₄ saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,

a group -COR ¹⁶ , where R ⁶ is a methyl, a C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄

saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,

a group -OCOR ⁷ , where R ⁷ is a methyl, a C ₂ -C ₃₀ -saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a -C ₂

- C ₃₀ - saturated or mono- or polyunsaturated, branched or linear mono-, di-, tri- or polyhydroxy hydrocarbon radical, a -C ₂ - C ₃₀ - saturated or mono- or polyunsaturated, branched or linear mono-, di-, , Tri- or polyaminocarbon residue, with the proviso that for the case when R ⁷ and R ^{8 are} -OH and at the same time R ⁹ or R ^{0 is} hydrogen, the remaining group R ⁹ or R ⁰ does not represent a dihydroxyethyl radical. In a particularly preferred embodiment of the teaching according to the invention, the compound corresponding to the formula (Fur-I) is (R) - (-) - 4-hydroxymethyl-T-butyrolactone and / or D, L-4-hydroxymethyl-γ-butyrolactone and / or (S) - (+) - 4-hydroxymethyl-γ-butyrolactone and / or R - (-) - 2-hydroxy-3,3-dimethyl-γ-butyrolactone and / or D, L-2-hydroxy-3 , 3-dimethyl-γ-butyrolactone and / or S (+) - 2-hydroxy-3,3-dimethyl-γ-butyrolactone and / or 4-hydroxy-2,5-dimethyl-3 (2H) -furanone and / or tetrahydro-5-oxo-2-furancarboxylic acid and / or tetrahydro-5-oxo-2-furancarboxylic acid, Na salt and / or tetrahydro-5-oxo-2-furancarboxylic acid, K salt and / or 2,5-dihydro -5-methoxy-2-furanone and / or dihydro-3-hydroxy-4,4-dimethyl-2 (3 / - /) - furanone used. In a very particularly preferred embodiment of the teaching according to the invention is used as a compound corresponding to the formula (Fur-I) dihydro-3-hydroxy-4,4-dimethyl-2 (3H) -furanone.

Another, more preferably usable care substance which has activating properties is taurine. According to the invention preferred hair treatment compositions contain - based on their weight - 0.01 to 15 wt .-%, preferably 0.025 to 12.5 wt .-%, particularly preferably 0.05 to 10 wt .-%, more preferably 0, 1 to 7 , 5 wt .-% and in particular 0.5 to 5 wt .-% taurine (2-aminoethanesulfonic acid).

 Another preferred group of care agents in the compositions of the invention are

Vitamins, provitamins or vitamin precursors. These are described below:

The group of substances referred to as vitamin A include retinol (vitamin A-1) and 3,4-didehydroretinol (vitamin A ₂ ). The ß-carotene is the provitamin of retinol. As a vitamin

A component according to the invention, for example, vitamin A acid and its esters,

Vitamin A aldehyde and vitamin A alcohol and its esters such as palmitate and acetate in

Consideration. The agents according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation.

 The vitamin B group or the vitamin B complex include u. a.

 Vitamin B-i (thiamine)

Vitamin B ₂ (riboflavin)

Vitamin B ₃ . Under this name, the compounds nicotinic acid and nicotinamide (niacinamide) are often performed. Preferred according to the invention is the nicotinic acid amide which is contained in the agents used according to the invention preferably in amounts of from 0.05 to 1% by weight, based on the total agent.

Vitamin B ₅ (pantothenic acid, panthenol and pantolactone). Panthenol and / or pantolactone are preferably used in the context of this group (see below). The said compounds of the vitamin B ₅ type are preferably contained in the agents according to the invention in amounts of 0.05-10% by weight, based on the total agent. Amounts of 0.1-5 wt .-% are particularly preferred.

Vitamin B ₆ (pyridoxine and pyridoxamine and pyridoxal). Vitamin C (ascorbic acid). Vitamin C is used in the inventive compositions preferably in amounts of 0, 1 to 3 wt .-%, based on the total agent. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.

 Vitamin E (tocopherols, especially α-tocopherol). Tocopherol and its derivatives, which include in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in the agents according to the invention in amounts of 0.05-1% by weight, based on the total agent.

 Vitamin F. The term "vitamin F" is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.

 Vitamin H. Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-cf] - imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile prevailed. Biotin is preferably present in the compositions according to the invention in amounts of from 0.0001 to 1.0% by weight, in particular in amounts of from 0.001 to 0.01% by weight.

In summary, hair-treatment compositions according to the invention are preferred which, based on their weight, are 0.1 to 5% by weight, preferably 0.2 to 4% by weight, more preferably 0.25 to 3.5% by weight, more preferably Contain 0.5 to 3 wt .-% and in particular 0.5 to 2.5 wt .-% vitamins and / or pro-vitamins and / or vitamin precursors, preferably the groups A, B, C, E, F and H. 2,4,4-dihydroxy-A / - (3-hydroxypropyl) -3,3-dimethylbutyramide, provitamin B ₅ ) and / or pantothenic acid (vitamin B ₃ , vitamin B ₅ ) and / or Niacin, niacinamide or nicotinamide (vitamin B ₃ ) and / or L-ascorbic acid (vitamin C) and / or thiamine (vitamin B) and / or riboflavin (vitamin B ₂ , vitamin G) and / or biotin (vitamin B ₇ , vitamin H) and / or folic acid (vitamin B ₉ , vitamin B _c or vitamin M) and / or vitamin B ₆ and / or vitamin B ₂ .

 It has been shown that certain quinones have a special suitability as a care substance. As a further care substance, the compositions according to the invention can therefore contain from 0.0001 to 5% by weight of at least one biochinone of the formula (Ubi)

contained in the

X, Y, Z are independently -O- or -NH- or NR ⁴ - or a chemical bond

R, R ² , R ³ independently represent a hydrogen atom or an optionally substituted aryl group or an optionally substituted (C ₁ -C ₆ ) -alkyl group or a hydroxyalkyl group or a polyhydroxyalkyl group or an optionally substituted (C ₁ -C ₆ ) -alkylene group, or a (C 1 -C ₆ ) -acyl radical, preferred radicals being selected independently of one another from -H, CH3, -CH2CH3, - (CH2) 2CH2, -CH (CH3) 2, - (CH2) 3CH3, -CH (CH3) CH2CH3, - CH ₂ CH (CH _{3) 2,} -C (CH _{3) 3}

R ⁴ is -CH ₃ , -CH ₂ CH ₃ , - (CH ₂ ) ₂ CH ₂ , -CH (CH ₃ ) ₂ ,

(CH ₂ ) ₃ CH ₃ , -CH (CH ₃ ) CH ₂ CH ₃ , -CH ₂ CH (CH ₃ ) ₂ , -C (CH ₃ ) ₃

 n stands for values from 1 to 20, preferably from 2 to 15 and in particular for 5, 6, 7, 8, 9, 10.

 Particularly preferred hair treatment compositions according to the invention are characterized in that they contain as care substance - based on their weight - 0.0001 to 1 wt .-%, preferably 0.001 to 0.5 wt .-% and particularly preferably 0.005 to 0, 1 wt .-% at least one ubiquinone and / or at least one ubiquinol and / or at least one derivative of these substances, preferred agents containing a ubiquinone of the formula (Ubi), in which n for the values = 6, 7, 8, 9 or 10, particularly preferred stands for 10 (coenzyme Q10).

 As an alternative to the particularly preferred ubiquinones or in addition to them, the agents according to the invention may also contain plastoquinones. Here, preferred agents according to the invention are characterized in that they are 0.0002 to 4 wt .-%, preferably 0.0005 to 3 wt .-%, particularly preferably 0.001 to 2 wt .-%, more preferably 0.0015 to 1 and in particular 0.002 to 0.5 wt .-% of at least one plastoquinone of the formula (Ubi-b)

in which n is from 1 to 20, preferably from 2 to 15 and in particular from 5, 6, 7, 8, 9, 10, with particular preference being given to plastoquinone PQ-9 of the formula Ubi-b, in which n = 9 is included.

As a further care enhancer, the agents according to the invention may contain ectoin. Ectoine ((4S) - 2-methyl-1, 4,5,6-tetrahydropyrimidine-4-carboxylic acid) is a natural product belonging to the group of compatible solutes. Hair treatment compositions which are preferred according to the invention are characterized in that they contain, based on their weight, from 0.001 to 10% by weight, preferably from 0.01 to 5% by weight, particularly preferably from 0.05 to 2.5% by weight and in particular from 0 , 1 to 1% by weight of (S) -2-methyl-1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid (ectoine) and the physiologically tolerated salts of this compound and / or (S, S) -5- Hydroxy-2-methyl-1, 4,5,6-tetrahydro-4 Pyrimidincarbonsäure (hydroxyectoine) and the physiologically acceptable salts of this compound.

 Another conditioner is allantoin. Allantoin (5-ureidohydantoin, A / - (2,5-dioxo-4-imidazolidinyl) urea) is used in cosmetics in skin creams, sunscreens, shampoos, toothpaste, and anti-sweating (hyperhidrosis) and skin irritants. It accelerates cell building, cell formation or cell regeneration and calms the skin. The healing of hard-healing wounds is also supported, but allantoin has no antiseptic properties.

According to the invention, particularly preferred hair-treatment compositions contain, based on their weight, from 0.001 to 10% by weight, preferably from 0.01 to 5% by weight, particularly preferably from 0.05 to 2.5% by weight and in particular from 0.1 to 1 5% ureidohydantoin (allantoin).

To improve the elasticity and strengthen the internal structure of the hair treated with the agents according to the invention, the compositions according to the invention may contain purine and / or purine derivatives as a care substance. In particular, the combination of purine and / or purine derivatives with ubiquinones and / or plastoquinones as a care substance means that the hairs treated with appropriate agents show, inter alia, higher measured values in differential thermal analysis and improved wet and dry combabilities.

Purine (7H-imidazo [4,5-cf] pyrimidine) is not freely present in nature, but forms the main body of the purines. Purines, in turn, are a group of important compounds of widespread nature involved in human, animal, plant and microbial metabolic processes, which differ from the parent by substitution with OH, NH ₂ , SH in the 2-, 6-, and 8-positions and / or with CH ₃ in 1-, 3-, 7-position derived. Purine can be prepared, for example, from aminoacetonitrile and formamide. Purines and purine derivatives are often isolated from natural products, but are also synthetically accessible in many ways.

Preferred agents according to the invention contain purine and / or purine derivatives in narrower quantitative ranges. Here, preferred cosmetic compositions according to the invention are characterized in that they contain, based on their weight, from 0.001 to 2.5% by weight, preferably from 0.0025 to 1% by weight, particularly preferably from 0.005 to 0.5% by weight and in particular 0.01 to 0, 1 wt .-% purine (s) and / or purine derivative (s).

Among purine, the purines and the purine derivatives, some representatives are particularly preferred according to the invention. According to preferred hair treatment compositions according to the invention are characterized in that they contain as care substance - based on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular 0.01 to 0, 1 wt .-% purine (s) and / or purine derivative (s), wherein preferred agents purine and / or purine derivative (s) of the formula (Pur-I)

in which the radicals R, R ² and R ^{3 are} independently selected from -H, - OH, NH ₂ , -SH and the radicals R ⁴ , R ⁵ and R ^{6 are} independently selected from -H, -CH ₃ and -CH ₂ - CH ₃ , the following compounds being preferred:

Purine (R = R ² = R ³ = R ⁴ = R ⁵ = R ⁶ = H)

Adenine (R = NH ₂ , R ² = R ³ = R ⁴ = R ⁵ = R ⁶ = H)

Guanine (R = OH, R ² = NH ₂ , R ³ = R ⁴ = R ⁵ = R ⁶ = H)

Uric acid (R = R ² = R ³ = OH, R ⁴ = R ⁵ = R ⁶ = H)

Hypoxanthine (R = OH, R ² = R ³ = R ⁴ = R ⁵ = R ⁶ = H)

6-Purethiol (R = SH, R ² = R ³ = R ⁴ = R ⁵ = R ⁶ = H)

6-thioguanine (R = SH, R ² = NH ₂ , R ³ = R ⁴ = R ⁵ = R ⁶ = H)

Xanthine (R = R ² = OH, R ³ = R ⁴ = R ⁵ = R ⁶ = H)

Caffeine (R = R ² = OH, R ³ = H, R ⁴ = R ⁵ = R ⁶ = CH ₃ )

Theobromine (R = R ² = OH, R ³ = R ⁴ = H, R ⁵ = R ⁶ = CH ₃ )

Theophylline (R = R ² = OH, R ³ = H, R ⁴ = CH ₃ , R ⁵ = CH ₃ , R '

 It is also advantageous to use purine or purine derivatives and biochinones in a certain ratio to each other. Here, agents according to the invention are preferred in which the weight ratio of purine (derivative (s)) and biochinone (s) is 10: 1 to 1: 100, preferably 5: 1 to 1:50, particularly preferably 2: 1 to 1:20 and in particular 1: 1 to 1:10.

As already mentioned, caffeine is a particularly preferred purine derivative, and coenzyme Q10 is a particularly preferred biochinone. Particularly preferred agents according to the invention are therefore characterized in that they contain, based on their weight, from 0.001 to 2.5% by weight, preferably from 0.0025 to 1% by weight, particularly preferably from 0.005 to 0.5% by weight and in particular 0.01 to 0, 1 wt .-% caffeine and 0.0002 to 4 wt .-%, preferably 0.0005 to 3 wt .-%, particularly preferably 0.001 to 2 wt .-%, more preferably 0.0015 to 1 and in particular 0.002 to 0.5 wt .-% coenzyme Q10 included.

 As a conditioner, the compositions of the invention may also contain flavonoids. The flavonoids are a group of water-soluble plant dyes and play an important role in the metabolism of many plants. They belong together with the phenolic acids to the polyphenols. There are well over 6500 different flavonoids known, which can be divided into flavonols, flavones, flavanones, isoflavonoids and anthocyanins.

According to the invention flavonoids from all six groups can be used, with certain representatives from the individual groups as a care substance because of their particularly intense Effect are preferred. Preferred flavonols are quercetin, rutin, kaempferol, myricetin, isorhamnetin, preferred flavanols are catechin, gallocatechin, epicatechin, epigallocatechin gallate, theaflavin, thearubigin, preferred flavones are luteolin, apigenin, morin, preferred flavanones are hesperetin, naringenin, eriodictyol, preferred isoflavonoids are genistein , Daidzein, and preferred anthocyanidins (anthocyanins) are cyanidin, delphinidin, malvidin, pelargonidin, peonidin, petunidin.

 According to the invention particularly preferred hair treatment compositions are characterized in that they - based on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular 0.01 to 0, 1 wt .-% flavonoids, especially flavonols, more preferably 3,3 ', 4', 5,7-Pentahydroxyflavon (quercetin) and / or 3,3 ', 4', 5,7-Pentahydroxyflavon -3-0-rutinoside (rutin), included.

 Preference is also the use of bisabolol and / or bisabololoxides as a care substance in the inventive compositions. Here, hair treatment compositions according to the invention are preferred which additionally contain 0.001 to 5 wt .-%, preferably 0.01 to 4 wt .-%, particularly preferably 0.02 to 2.5 wt .-% and in particular 0.1 to 1, 5 wt % Bisabolol and / or oxides of bisabolol, preferably (-) - alpha-bisabolol.

 Creatine is also suitable as a care substance according to the invention. Particularly preferred hair treatment compositions according to the invention contain - based on their weight - 0.01 to 15 wt .-%, preferably 0.025 to 12.5 wt .-%, particularly preferably 0.05 to 10 wt .-%, more preferably 0, 1 bis 7.5 wt .-% and in particular 0.5 to 5 wt .-% / V-methyl-guanidino-acetic acid (creatine).

 The compositions according to the invention may contain, in addition to the ingredients mentioned above and optional further ingredients, other substances which prevent, alleviate or cure hair loss. In particular, a content of hair root stabilizing agents is advantageous. These substances are described below:

Propecia (finasteride) is currently the only product approved worldwide that has been proven efficacy and tolerability in numerous studies. Propecia causes less DHT to be produced from testosterone.

Minoxidil is probably the oldest proven hair restorer with or without supplemental additives. For the treatment of hair loss, it may only be used for external application. There are hair lotions containing 2% -5% minoxidil, as well as gels with up to 15% minoxidil. The effectiveness increases with the dosage, in hair waters Minoxidil is only up to 5% share soluble. In many countries, hair tonic with up to 2% minoxidil content is available without prescription.

To combat the hormonal effects on hair follicles, spironolactone in the form of hair tonic and in combination with minoxidil can be used for external application. Spironolactone acts as an androgen receptor blocker, ie the binding of DHT to the hair follicles is prevented.

In summary, hair treatment compositions according to the invention are preferred which additionally contain, based on their weight, from 0.001 to 5% by weight of hair root stabilizing substances, in particular minoxidil and / or finasteride and / or ketoconazole.

 Additional antidandruff active ingredients (for example climbazole, piroctone olamine or zinc pyrithione) are used to purposefully reduce the amount of dandruff causing the dandruff, to restore the normal bacterial count to the normal percentage and to reduce the scaling to the physiological level. However, laboratory tests have shown that the different species representatives of Pityrosporum ovale react differently to the antidandruff active ingredients. In order to maximally combat all dandruff is therefore a combination of anti-dandruff active ingredients most successful.

 In summary, hair treatment compositions according to the invention are preferred which additionally contain, based on their weight, from 0.001 to 5% by weight of antidandruff active ingredients, in particular piroctone olamine (1-hydroxy-4-methyl-6- (2,4,4-tri-methylpentyl) -pyridine-2 ( 1 H) -one, compound with 2-aminoethanol, 1: 1) and / or zinc pyrithione and / or selenium sulfide and / or climbazole and / or salicylic acid or fumaric acid.

 In addition to the care agents, the agents according to the invention may contain further care substances. Their presence is not absolutely necessary for achieving the effects according to the invention, but further effects, such as a pleasant touch or a pleasant application feel, can result from the use of these care substances.

 As a further ingredient, the agents according to the invention may with particular preference contain one or more amino acids. Particularly preferred amino acids which can be used according to the invention are from the group glycine, alanine, valine, leucine, isoleucine, phenylalanine, tyrosine, tryptophan, proline, aspartic acid, glutamic acid, asparagine, glutamine, serine, threonine, cysteine, methionine, lysine, arginine, histidine, β Alanine, 4-aminobutyric acid (GABA), betaine, L-cystine (L-Cyss), L-carnitine, L-citrulline, L-theanine, 3 ', 4'-dihydroxy-L-phenylalanine (L-dopa), 5'-hydroxy-L-tryptophan, L-homocysteine, S-methyl-L-methionine, S-allyl-L-cysteine-sulfoxide (L-alliin), L-trans-4-hydroxyproline, L-5-oxoproline ( L-pyroglutamic acid), L-phosphoserine, creatine, 3-methyl-L-histidine, L-ornithine, whereby both the individual amino acids and mixtures can be used.

Preferred agents according to the invention contain one or more amino acids in narrower quantitative ranges. Here, preferred hair treatment compositions according to the invention are characterized in that they contain as care substance - based on their weight - 0.01 to 5 wt .-%, preferably 0.02 to 2.5 wt .-%, particularly preferably 0.05 to 1, 5 Wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0.1 to 0.25 wt .-% amino acid (s), preferably from the group of glycine and / or alanine and / or valine and / or lysine and / or leucine and / or threonine. As a further component, the agents according to the invention may contain at least one carbohydrate from the group of monosaccharides, disaccharides and / or oligosaccharides. Here, preferred hair treatment compositions according to the invention are characterized in that they contain as care substance - based on their weight - 0.01 to 5 wt .-%, preferably 0.05 to 4.5 wt .-%, particularly preferably 0.1 to 4 wt. -%, more preferably 0.5 to 3.5 wt .-% and in particular 0.75 to 2.5 wt .-% carbohydrate (s) selected from monosaccharides, disaccharides and / or oligosaccharides containing preferred carbohydrates are selected out

 Monosaccharides, in particular D-ribose and / or D-xylose and / or L-arabinose and / or D-glucose and / or D-mannose and / or D-galactose and / or D-fructose and / or sorbose and / or L. Fucose and / or L-rhamnose

 Disaccharides, in particular sucrose and / or maltose and / or lactose and / or trehalose and / or cellobiose and / or gentiobiose and / or isomaltose.

Particularly preferred agents according to the invention contain based on their weight

 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of glucose monohydrate,

0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose,

0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of fructose.

 As already mentioned, preferred agents according to the invention contain (a) amino acid (s).

Particularly preferred amino acids which can be used according to the invention are from the group glycine, alanine, valine, leucine, isoleucine, phenylalanine, tyrosine, tryptophan, proline, aspartic acid, glutamic acid, asparagine, glutamine, serine, threonine, cysteine, methionine, lysine, arginine, histidine, β Alanine, 4-aminobutyric acid (GABA), betaine, L-cystine (L-Cyss), L-carnitine, L-citrulline, L-theanine, 3 ', 4'-dihydroxy-L-phenylalanine (L-dopa), 5'-hydroxy-L-tryptophan, L-homocysteine, S-methyl-L-methionine, S-allyl-L-cysteine-sulfoxide (L-alliin), L-frans-4-hydroxyproline, L-5-oxoproline ( L-pyroglutamic acid), L-phosphoserine, creatine, 3-methyl-L-histidine, L-ornithine, whereby both the individual amino acids and mixtures can be used.

 Preferred agents according to the invention contain one or more amino acids in narrower quantitative ranges. Here, preferred cosmetic compositions according to the invention are characterized in that they additionally contain from 0.05 to 5% by weight, preferably from 0.1 to 2.5% by weight, more preferably from 0.15 to 1% by weight and in particular from 0 , 2 to 0.5 wt .-% amino acid (s), preferably (one) amino acid (s) from the group glycine and / or alanine and / or valine and / or lysine and / or leucine and / or threonine.

Particularly preferred agents according to the invention contain based on their weight

 0.005 to 0.015 wt .-% caffeine and 0.75 to 1, 5 wt .-% glucose monohydrate and

0.1 to 0.25% by weight of glycine,

 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose and 0.1 to 0.25% by weight of glycine,

0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of fructose and 0.1 to 0.25% by weight of glycine, 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of glucose monohydrate and 0.1 to 0.25% by weight of alanine,

 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose and 0.1 to 0.25% by weight of alanine,

 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of fructose and 0.1 to 0.25% by weight of alanine,

 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of glucose monohydrate and 0.1 to 0.25% by weight of valine,

 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose and 0.1 to 0.25% by weight of valine,

 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of fructose and 0.1 to 0.25% by weight of valine.

 As a further optional constituent, the agents according to the invention may contain from 0.01 to 10% by weight of at least one polymer from the group of cationic and / or amphoteric polymers.

 Cationic or amphoteric polymers are to be understood as meaning polymers which have a group in the main and / or side chain which may be "temporary" or "permanent" cationic. According to the invention, "permanently cationic" refers to those polymers which have a cationic group, irrespective of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group. Preferred cationic groups are quaternary ammonium groups. In particular, those polymers in which the quaternary ammonium group is bonded via a C 1-4 hydrocarbon group to a polymer main chain constructed from acrylic acid, methacrylic acid or derivatives thereof have proven to be particularly suitable.

 In addition to cationic polymers or in their place, the agents according to the invention can also contain amphoteric polymers. These additionally have at least one negatively charged group in the molecule and are also referred to as zwitterionic polymers.

Preferably, the polymer or polymers are used within narrower ranges. Thus, preference is given to compositions according to the invention which, based on their weight, are from 0.05 to 7.5% by weight, preferably from 0.1 to 5% by weight, particularly preferably from 0.2 to 3.5% by weight and in particular from 0.25 to 2.5% by weight of amphoteric polymer (s).

 Regardless of whether the agents contain amphoteric polymers or not, further preferred agents according to the invention are characterized in that they contain, based on their weight, from 0.05 to 7.5% by weight, preferably from 0.1 to 5% by weight. -%, particularly preferably 0.2 to 3.5 wt .-% and in particular 0.25 to 2.5 wt .-% cationic (s) polymer (s) included.

Cationic polymers which can preferably be used according to the invention are described below: Homopolymers of the general formula (G1-I),

R ¹

 I

- [CH ₂ -C-] _n X- (G1-I)

 I

CO-O- (CH ₂ ) _m -N ⁺ R ² R ³ R ⁴ in which R = -H or -CH ₃ , R ² , R ³ and R ^{4 are} independently selected from C 1-4 -alkyl, Alkenyl or hydroxyalkyl groups, m = 1, 2, 3 or 4, n is a natural number and X ^"is a physiologically acceptable organic or inorganic anion, as well as copolymers consisting essentially of the monomer units listed in formula (G1-I) and nonionic monomer units, are particularly preferred cationic polymers. Within the scope of these polymers, preference is given to those according to the invention for which at least one of the following conditions applies:

 R is a methyl group

R ² , R ³ and R ⁴ are methyl groups

 m has the value 2.

Suitable physiologically tolerated counterions X ^" are, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions, preference being given to halide ions, in particular chloride.

A particularly suitable homopolymer is, if desired, crosslinked, poly (methacryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium 37. The homopolymer is preferably used in the form of a non-aqueous polymer dispersion, which should have a polymer content of not less than 30 wt .-%. Such polymer dispersions are (under the names Salcare ^® SC 95 about 50% polymer content, additional components: mineral oil (INCI name: Mineral Oil) and tridecyl-polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1 trideceth-6) ) and Salcare ^® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene glycol with a mixture of caprylic and capric acid (INCI name: propylene glycol Dicaprylate / Dicaprate) and tridecyl polyoxypropylene-polyoxyethylene-ether (INCI Designation: PPG-1-trideceth-6)) are commercially available.

Copolymers contain monomer units having the formula (G1-I) as a non-ionic monomer, preferably acrylamide, methacrylamide, acrylic acid and methacrylic acid alkyl esters CI_ ₄ d-4-alkyl ester. Among these nonionic monomers, the acrylamide is particularly preferred. These copolymers can also be crosslinked, as described above in the case of the homopolymers. A copolymer preferred according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer. Such copolymers in which the monomers are present in a weight ratio of about 20:80, are commercially available as approximately 50% non-aqueous polymer dispersion 92 under the name Salcare ^® SC. Further preferred cationic polymers are, for example

 quaternized cellulose derivatives,

 cationic alkyl polyglycosides,

 cationized honey,

 cationic guar derivatives,

 polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of acrylic acid and methacrylic acid.

 Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate, such as diethyl sulfate quaternized vinylpyrrolidone-dimethylaminoethyl methacrylate copolymers.

 Vinylpyrrolidone-vinyl imidazolium copolymers,

 quaternized polyvinyl alcohol,

 and the polymers known under the names Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 and Polyquaternium 27 with quaternary nitrogen atoms in the polymer main chain.

Can be used as cationic polymers are sold under the names Polyquaternium-24 (commercial product z. B. Quatrisoft ^® LM 200), known polymers. Also usable in the invention are the copolymers of vinylpyrrolidone, such as the commercial products Copolymer 845 (manufactured by ISP), Gaffix ^® VC 713 (manufactured by ISP), Gafquat ^® ASCP 101 1, Gafquat ^® HS 1 10, Luviquat ^® 8155 and Luviquat ^® MS 370 are available. Cationic protein hydrolysates may also be used as cationic polymers, preferred agents being one or more cationic protein hydrolyzates from the group Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Hydroxypropyl Arginine Lauryl / Myristyl Ether HCl, Hydroxypropyltrimonium Gelatin, Hydroxypropyltrimonium Hydrolyzed Casein, Hydroxypropyltrimonium Hydrolyzed Collagen, Hydroxypropyltrimonium Hydrolyzed Conchiolin Protein, Hydroxypropyltrimonium Hydrolyzed Keratin, Hydroxypropyltrimonium Hydrolyzed Rice Bran Protein , Hydroxypropyltrimonium Hydrolyzed Soy Protein, Hydroxypropyl Hydrolyzed Vegetable Protein, Hydroxypropyltrim Hydrolyzed Wheat Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein / Siloxysilicate, Lauridimonium Hydroxypropyl Hydrolyzed Soy Protein, Laurodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Laurodimonium Hydroxypropyl Hydrolyzed Wheat Protein / Siloxysilicate, Lauryldimonium Hydroxypropyl Hydrolyzed Casein, Lauryldimonium Hydroxypropyl Hydrolyzed Collagen, Lauryldimonium Hydroxypropyl Hydrolyzed Keratin, Lauryldimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Casein, Steardimonium Hydroxypropyl Hydrolyzed Collagen, Steardimonium Hydroxypropyl Hydrolyzed Keratin, Steardimonium Hydroxypropyl Hydrolyzed Rice Protein, Steardimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Vegetable Protein, Steardimonium Hydroxypropyl Hydrolyzed Wheat Protein, Steartrimonium Hydroxyethyl Hydrolyzed Collagen, Quaternium-76 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Keratin, Quaternium-79 Hydrolyzed Milk Protein, Quaternium-79 Hydrolyzed Soy Protein, Quaternium-79 Hydrolyzed Wheat Protein.

In summary, agents according to the invention are preferred which, based on their weight, are from 0.05 to 7.5% by weight, preferably from 0.1 to 5% by weight, particularly preferably from 0.2 to 3.5% by weight and in particular from 0.25% to 2.5% by weight of cationic polymer (s), preferred cationic polymer (s) being / are selected from

Poly (methacryloyloxyethyltrimethylammonium chloride) (INCI: Polyquaternium-37) and / or; quaternized cellulose derivatives, in particular Polyquaternium 10 and / or Polyquaternium 67, and / or cationic alkylpolyglycosides and / or cationized honey and / or cationic guar derivatives and / or polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of acrylic acid and methacrylic acid and / or Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate and / or vinylpyrrolidone-Vinylimidazoliummethochlorid copolymers and / or quaternized polyvinyl alcohol and / or Polyquaternium 2 and / or Polyquaternium-7 and / or Polyquaternium- 16 and / or Polyquaternium 17 and / or Polyquaternium 18 and / or Polyquaternium 24 and / or Polyquaternium 27 and / or Polyquaternium 74.

 In addition to the cationic polymers or in their place, the agents of the invention may contain amphoteric polymers. In the context of the present invention preferably usable amphoteric polymers are composed essentially together

 A) monomers having quaternary ammonium groups of the general formula (Z-1),

R ¹ -CH = CR ² -CO-Z- (C _n H _2n ) -N ( ⁺ ) R ³ R ⁴ R ⁵ A <^" ) ( ^{Ζ ~} ')

In which R and R ² independently represent hydrogen or a methyl group and

R ³ , R ⁴ and R 1 are independently alkyl groups having 1 to 4 carbon atoms, Z is an NH group or an oxygen atom, n is an integer from 2 to 5 and A (~) is the anion of an organic or inorganic acid and

 B) monomeric carboxylic acids of the general formula (Z-II),

R ⁶ -CH = CR ⁷ -COOH (Z-II)

in which R ^ and R ^{7 are} independently hydrogen or

Are methyl groups. Suitable starting monomers are, for. Dimethylaminoethylacrylamide, dimethylaminoethylmethacrylamide, dimethylaminopropylacrylamide, dimethylaminopropylmethacrylamide and diethylaminoethylacrylamide when Z is an NH group or dimethylaminoethyl acrylate, dimethylaminoethyl methacrylate and diethylaminoethyl acrylate when Z is an oxygen atom.

 The monomers containing a tertiary amino group are then quaternized in a known manner, methyl chloride, dimethyl sulfate or diethyl sulfate being particularly suitable as alkylating reagents. The quaternization reaction can be carried out in aqueous solution or in the solvent.

 Advantageously, such monomers of formula (Z-1) will be the derivatives of acrylamide or methacrylamide. Preference is furthermore given to those monomers which contain halide, methoxysulfate or ethoxysulfate ions as counterions. Likewise preferred are those

Monomers of the formula (Z-1) in which R, R and R ° are methyl groups.

 The acrylamidopropyltrimethylammonium chloride is a most preferred monomer of formula (Z-1).

 Suitable monomeric carboxylic acids of the formula (Z-II) are acrylic acid, methacrylic acid, crotonic acid and 2-methylcrotonic acid. Preference is given to using acrylic or methacrylic acid, in particular acrylic acid.

 Particularly effective polymers have proven to be in which the monomers of the formula (Z-l) were present in excess over the monomers of the formula (Z-II). It is therefore preferred in accordance with the invention to use those polymers which consist of monomers of the formula (ZI) and the monomers of the formula (Z-II) in a molar ratio of 60:40 to 95: 5, in particular 75:25 to 95: 5 , consist.

 Agents preferred according to the invention are characterized in that the amphoteric polymer (s) comprise monomers A) and B), wherein A) and B) are selected from

 A) monomers having quaternary ammonium groups of the general formula (Z-1),

R ¹ -CH = CR ² -CO-Z- (C _n H _2n ) -N ( ⁺ ) R ³ R ⁴ R ⁵ A ( ^" ) ( ^Z_L )

in which R and R ² independently represent hydrogen or a

Methyl group and R, R and R ° independently of one another for alkyl groups having 1 to 4 carbon atoms, Z is an NH group or an oxygen atom, n is an integer

Number of 2 to 5 and A (-) is the anion of an organic or inorganic acid and

 B) monomeric carboxylic acids of the general formula (Z-II),

R ⁶ -CH = CR ⁷ -COOH (Z-II)

in which R ^ and 7 are independently hydrogen or methyl groups. With particular preference, the amphoteric polymers used in the agents according to the invention contain monomers from the group of acrylamides and / or methacrylamides Alkylammonium. Acrylic acid and / or methacrylic acid and / or crotonic acid and / or 2-methyl-crotonic acid have proven useful as monomers with anionic groups which are additionally present in the polymers.

 In summary, agents according to the invention are preferred in which the amphoteric polymer (s) are co-polymers of at least one of the monomers trimethylammoniumethylacrylamide and / or, trimethylammoniumethylmethacrylamide and / or trimethylammoniumpropylacrylamide and / or trimethylammoniumpropylmethacrylamide and / or trimethylammoniumethylacrylamide and / or trimethylammoniumethylacrylate and / or or trimethylammoniumethylmethacrylate and / or trimethylammoniumethylacrylate and / or ethyldimethylammoniumethylacrylamide and / or, ethyldimethylammoniumethylmethacrylamide and / or ethyldimethylammoniumpropylacrylamide and / or ethyldimethylammoniumpropylmethacrylamide and / or

Ethyldimethylammoniumethylacrylamide and / or ethyldimethylammoniumethylacrylate and / or ethyldimethylammoniumethylmethacrylate and / or ethyldimethylammoniumethylacrylate having at least one of the monomers acrylic acid and / or methacrylic acid and / or crotonic acid and / or 2-methylcrotonic acid.

 It has furthermore proven to be advantageous if, in addition to the polymer (s) from the group of cationic and / or amphoteric polymers, further polymers (G) are contained in the agents according to the invention. In a preferred embodiment, therefore, further polymers are added to the compositions according to the invention, both anionic and nonionic polymers having proven effective.

 The anionic polymers (G2) are anionic polymers which have carboxylate and / or sulfonate groups. Examples of anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid. The acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt. Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.

Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer can be found to be particularly effective, it being possible for all or some of the sulfonic acid group to be present as sodium, potassium, ammonium, mono- or triethanolammonium salt ,

More preferably, the homopolymer of 2-acrylamido-2-methyl propane sulfonic acid, which is commercially available, for example under the name Rheothik ^® 1 1-80 is.

Within this embodiment, it may be preferable to use copolymers of at least one anionic monomer and at least one nonionic monomer. With regard to the anionic monomers, reference is made to the substances listed above. Preferred nonionic monomers are acrylamide, methacrylamide, acrylic esters, methacrylic esters, vinylpyrrolidone, vinyl ethers and vinyl esters. Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers. A particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid group is wholly or partly in the form of sodium, potassium, ammonium, mono- or triethanolammonium Salt is present. This copolymer may also be crosslinked, with crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene-bisacrylamide are used. Likewise preferred anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ^® commercially.

Copolymers of maleic anhydride and methyl vinyl ether, especially those with crosslinks, are also color-retaining polymers. A 1, 9-decadiene crosslinked maleic acid methyl vinyl ether copolymer is available under the name ^® Stabileze QM.

In another embodiment, the agents according to the invention may contain nonionic polymers (G4).

 Suitable nonionic polymers are, for example:

 Vinylpyrrolidone / Vinylester copolymers,

 Cellulose ethers, such as hydroxypropylcellulose, hydroxyethylcellulose and methylhydroxypropylcellulose,

 Starch and its derivatives, especially starch ethers,

 shellac

 polyvinylpyrrolidones,

 Siloxanes. Preferred siloxanes are polydialkylsiloxanes, such as, for example, polydimethylsiloxane, polyalkylarylsiloxanes, such as, for example, polyphenylmethylsiloxane, ethoxylated polydialkylsiloxanes and polydialkylsiloxanes which contain amine and / or hydroxyl groups. Glycosidically substituted silicones.

It is also possible according to the invention that the preparations comprise a plurality of, in particular two, different polymers of the same charge and / or in each case an ionic and an amphoteric and / or nonionic polymer.

 The other polymers (G) are contained in the agents according to the invention preferably in amounts of 0.05 to 10 wt .-%, based on the total agent. Amounts of 0, 1 to 5, in particular from 0.1 to 3 wt .-%, are particularly preferred.

 A particularly preferred group of ingredients are the silicones.

 Preferred agents according to the invention are characterized in that they contain at least one

Silicon included.

Particularly preferred compositions according to the invention comprise the silicone (s) preferably in amounts of from 0.1 to 10% by weight, preferably from 0.25 to 7% by weight and in particular from 0.5 to 5% by weight. , in each case based on the total mean. Preferred silicones are described below.

 Particularly preferred agents according to the invention are characterized in that they contain at least one silicone of the formula Si-I

(CH ₃ ) ₃ Si - [0-Si (CH ₃ ) 2] x -O-Si (CH ₃ ) 3 (Si-I),

in which x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and in particular 0 to 10.

These silicones are called DIMETHICONE according to the INCI nomenclature. In the context of the present invention, the following compounds are preferably those compounds of the formula Si-I: (CH ₃ ) ₃ Si-O-Si (CH ₃ ) 3, (CH ₃ ) ₃ Si-O- (CH ₃ ) ₂ Si-O -Si (CH _{3) 3,} (CH _{3) 3} Si- [0- (CH _{3) 2} Si] ₂ -0-Si (CH _{3) 3,} (CH _{3) 3} Si- [0- (CH _{3) 2} Si] ₃ -0-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [0- (CH ₃ ) ₂ Si] ₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [ 0- (CH ₃ ) ₂ Si] ₅ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si - [0- (CH ₃ ) ₂ Si] ₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [0- (CH ₃ ) ₂ Si] ₇ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [0- (CH ₃ ) ₂ Si] ₈ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [0- (CH ₃ ) ₂ Si] ₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₀ -O-Si (CH _{3) 3,} (CH _{3) 3} Si- [0- (CH ₃₎ 2 Si] i i-0-Si (CH3) 3, (CH _{3) 3} Si- [0- (CH ₃ ) ₂ Si] ₁₂ -0-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si - [0- (CH ₃ ) ₂ Si] ₁₃ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [0- (CH ₃ ) ₂ Si] ₁₄ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [0- (CH ₃ ) ₂ Si] ₁₅ -O-Si (CH ₃ ) ₃ , ( CH ₃ ) ₃ Si [0- (CH ₃ ) ₂ Si] ₁₆ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si [0- (CH ₃ ) ₂ Si] ₁₇ -O-Si ( CH ₃ ) ₃ , (CH ₃ ) ₃ Si [0- (CH ₃ ) ₂ Si] ₁₈ -O- Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si - [0- (CH ₃ ) ₂ Si] ₁₉ -O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si - [O- (CH ₃ ) ₂ Si] ₂₀ -O-Si (CH ₃ ) ₃ , wherein (CH ₃ ) ₃ Si-O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si-O- (CH ₃ ) ₂ Si-0-Si (CH ₃ ) ₃ and / or (CH ₃ ) ₃ Si [0- (CH ₃ ) ₂ Si] ₂ -O-Si (CH ₃ ) _{3 are} particularly preferred.

 Of course, mixtures of the o. Silicones may be included in the compositions of the invention.

 Particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.1 to 10% by weight, preferably from 0.25 to 7% by weight and in particular from 0.5 to 5% by weight of silicone (e ) of the formula Si-I

(CH ₃ ) ₃ Si - [0-Si (CH ₃ ) ₂ ] _x -O-Si (CH ₃ ) ₃ (Si-I),

in which x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and in particular 0 to 10.

Preferred silicones which can be used according to the invention have viscosities of 0.2 to 2 mm ² s ^-1 at 20 ° C., silicones having viscosities of 0.5 to 1 mm ² s ^{-1 being} particularly preferred.

Particularly preferred agents according to the invention contain one or more amino-functional silicones. Such silicones may e.g. through the formula

M (R _a Q _b SiO ₍ 4-ab) / 2) x (R _c SiO (4- _c ) / ₂ ) yM

wherein R in the above formula is a hydrocarbon or a hydrocarbon radical having 1 to about 6 carbon atoms, Q is a polar radical of the general formula -R HZ, wherein R is a divalent linking group attached to hydrogen and the radical Z. Z is an organic, amino-functional radical containing at least one amino-functional group; "a" assumes values in the range of about 0 to about 2, "b" assumes values in the range of about 1 to about 3, "a" + "b" is less than or equal to 3, and "c" is a number in the range from about 1 to about 3 and x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25, and y is a number ranging from about 20 to about 10,000, preferably from about 125 to about 10,000, and most preferably from about 150 to about 1,000, and M is a suitable silicone end group as known in the art, preferably trimethylsiloxy. Non-limiting examples of the groups represented by R include alkyl groups such as methyl, ethyl, propyl, isopropyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur containing radicals such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; preferably R is an alkyl radical containing from 1 to about 6 carbon atoms, and most preferably R is methyl. Examples of R include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH ₂ CH (CH ₃ ) CH ₂ -, phenylene, naphthylene, -CH ₂ CH ₂ SCH ₂ CH ₂ -, - CH ₂ CH ₂ OCH ₂ -, -OCH ₂ CH ₂ -, -OCH ₂ CH ₂ CH ₂ -, -CH ₂ CH (CH ₃ ) C (O) ₂ -, - (CH ₂ ) ₃ CC (O) OCH ₂ CH ₂ -, -C ₆ H ₄ C ₆ H ₄ -, -C ₆ H 4 CH ₂ C ₆ H ₄ -; and - (CH 2) ₃ C (O) SCH ₂ CH 2 -.

Z is an organic, amino-functional radical containing at least one functional amino group. A possible formula for Z is NH (CH ₂ ) _Z NH ₂ , wherein z is 1 or more. Another possible formula for Z is -NH (CH ₂ ) _Z (CH ₂ ) zzNH, where both z and zz are independently 1 or more, this structure comprising diamino ring structures, such as piperazinyl. Z is most preferably a -NHCH ₂ CH ₂ NH ₂ radical. Another possible formula for Z is -N (CH ₂ ) z (CH ₂ ) zzNX ₂ or -NX ₂ , wherein each X of X _{2 is} independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz is 0 ,

Q is most preferably a polar, amine functional group of the formula -CH ₂ CH ₂ CH ₂ NHCH ₂ CH ₂ NH ₂ . In the formulas, "a" assumes values in the range of about 0 to about 2, "b" assumes values in the range of about 2 to about 3, "a" + "b" is less than or equal to 3, and "c "is a number in the range of about 1 to about 3. The molar ratio of the R _a Q _b SiO _{(4 a} . _{b) / 2} units to the R _c SiO (4- _C ) / 2 units is in the range from about 1: 2 to 1:65, preferably from about 1: 5 to about 1:65, and most preferably from about 1:15 to about 1:20. When one or more silicones of the above formula are used, then the various variables can be used Substituents in the above formula may be different for the various silicone components present in the silicone blend.

 Preferred agents according to the invention are characterized in that they contain an amino-functional silicone of the formula (Si-II)

R _'a G 3-a -Si (OSiG ₂₎ n (OSiG _b R'2- _{b) m} -0-SiG3-a-R'a (Si-II),

 contain, in which means:

- G is -H, a phenyl group, -OH, -O-CH ₃ , -CH ₃ , -O-CH ₂ CH ₃ , -CH ₂ CH ₃ , -O-CH ₂ CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -O-CH (CH 3 ) 2, -CH (CH 3) 2, -O-CH 2 CH 2 CH 2 CH 3, CH ₂ CH ₂ CH ₂ CH _3, -O-CH ₂ CH (CH ₃ ) ₂ , -CH ₂ CH (CH ₃ ) ₂ , -O-CH (CH ₃ ) CH ₂ CH ₃ , - CH (CH ₃ ) CH ₂ CH ₃ , -O -C (CH ₃ ) ₃ , -C (CH ₃ ) ₃ ;

 a is a number between 0 and 3, in particular 0;

 b is a number between 0 and 1, in particular 1,

 m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n is preferably values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10,

- R ^' is a monovalent radical selected from

o -QN (R ") - CH ₂ -CH ₂ -N (R") ₂

o -QN (R ") ₂

o -QN ⁺ (R ") ₃ A ^"

o -QN ⁺ H (R ") ₂ A ^"

o -QN ⁺ H ₂ (R ") A ^"

o -QN (R ") - CH ₂ -CH ₂ -N ⁺ R" H ₂ A ^" ,

wherein each Q is a chemical bond, -CH ₂ -, -CH ₂ -CH ₂ -, -CH ₂ CH ₂ CH ₂ -, -C (CH ₃ ) ₂ -, -CH ₂ CH ₂ CH ₂ CH ₂ -, -CH ₂ C (CH ₃ ) ₂ -, -CH (CH ₃ ) CH ₂ CH ₂ -,

R "represents identical or different radicals from the group -H, -phenyl, -benzyl, -CH ₂ - CH (CH ₃₎ Ph, the C- | ₂₀ -alkyl, preferably -CH _3, -CH ₂ CH _3. -CH ₂ CH ₂ CH ₃ , - CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ H ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , -C ( CH ₃ ) ₃ , and A represents an anion, which is preferably selected from chloride, bromide, iodide or methosulfate.

 Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si-IIa)

(CH ₃ ) ₃ Si [0-Si (CH ₃ ) ₂ ] _n [OSi (CH ₃ )] _m -OSi (CH ₃ ) ₃ (Si-Ila),

 I

CH ₂ CH (CH ₃ ) CH ₂ NH (CH ₂ ) ₂ NH ₂

in which m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.

These silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration. Particular preference is also given to compositions according to the invention which are an amino-functional silicone of the formula (Si-IIb)

R- [Si (CH _{3) 2} -0] _n1 [Si (R) -0] _m - [Si (CH _{3) 2] n2} -R (Si-IIb),

 I

(CH ₂ ) ₃ NH (CH ₂ ) ₂ NH ₂

in which R is -OH, -O-CH ₃ or a -CH ₃ group and m, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150 . wherein the sum (n1 + n2) preferably takes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.

These silicones are referred to as amodimethicones according to the INCI declaration.

Regardless of which amino-functional silicones are used, agents according to the invention which contain an amino-functional silicone whose amine number is above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g, are preferred , The amine number stands for the milliequivalents of amine per gram of the amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g.

Agents preferred according to the invention are characterized in that, based on their weight, they contain 0.01 to 10% by weight, preferably 0.1 to 8% by weight, more preferably 0.25 to 7.5% by weight and in particular 0, 5 to 5 wt.% Amino-functional silicone (s) included.

In summary, particularly preferred hair treatment compositions according to the invention are characterized in that they contain, based on their weight, from 0.1 to 10% by weight, preferably from 0.25 to 7% by weight and in particular from 0.5 to 5% by weight of silicone ( e) of the formula Si-lia and / or Si-Ilb

(CH ₃ ) ₃ Si - [O-Si (CH ₃ ) 2] n [OSi (CH ₃ )] _m - OSi (CH ₃ ) 3 (Si-Ila),

 I

CH ₂ CH (CH 3) CH ₂ NH (CH ₂ ) ₂ NH ₂

R- [Si (CH _{3) 2} -0] _n1 [Si (R) -0] _k - [Si (CH _{3) 2] n2} -R (Si-IIb),

 I

(CH ₂ ) ₃ NH (CH ₂ ) ₂ NH ₂

contain, in which

 om and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n is preferably values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10

o R is -OH, -O-CH ₃ or a -CH ₃ group

 ok, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2000, preferably between 50 and 150, the sum (n1 + n2) preferably being values from 0 to 1999 and especially from 49 to 149 and m preferably assumes values of from 1 to 2000, in particular from 1 to 10.

The INCI CYCLOMETHICONE designated cyclic dimethicones are inventively used with preference. Here, agents according to the invention are preferred which contain at least one silicone of the formula Si-III

 fO-SiiCH,),!, - (Si-III), in which x is a number from 3 to 200, preferably from 3 to 10, more preferably from 30 to 7 and in particular 3, 4, 5 or 6.

The silicones described above have a backbone consisting of -Si-O-Si units is constructed. Of course, these Si-O-Si units may also be interrupted by carbon chains. Appropriate molecules are accessible by chain extension reactions and are preferably used in the form of silicone-in-water emulsions.

 Agents which are likewise preferred according to the invention are characterized in that they contain at least one silicone of the formula Si-IV

R _{3 is} -Si- [O-SiR 2] x- (CH ₂ ) _n - [O-SiR ₂ ] _y -O-SiR 3 (Si-IV),

in which R is identical or different radicals from the group -H, -phenyl, -benzyl, -CH ₂ -CH (CH ₃ ) Ph, the Ci_ ₂ o-alkyl radicals, preferably -CH ₃ , CH ₂ CH 3, - CH ₂ CH ₂ CH 3, -CH (CH3) _2, -CH ₂ CH ₂ CH ₂ H 3, -CH ₂ CH (CH 3) _2, -CH (CH3) _CH2 CH3, -C (CH3) 3, x or y is a number from 0 to 200, preferably from 0 to 10, more preferably from 0 to 7 and especially 0, 1, 2, 3, 4, 5 or 6, and n is a number from 0 to 10 , preferably from 1 to 8 and especially for 2, 3, 4, 5, 6 stands.

 The silicones are preferably water-soluble. Agents preferred according to the invention are characterized in that they contain at least one water-soluble silicone.

The compositions according to the invention have advantageous properties and also confer advantageous properties on the hair treated with them. Benefits have been observed particularly in hair conditioning. Thus, hair treatment compositions according to the invention improve the grip and the combabilities in the dry and wet state of the hair treated with them. It also shows prevention of premature splitting in the treated hair without compromising volume and fullness. Overall, softness, suppleness and shine are significantly improved.

 Another object of the present invention is therefore a process for the purification of keratinic fibers, characterized in that a hair treatment composition containing - based on its weight - a) 0.01 to 40 wt .-% of 3-methyl-1, 3-butanediol,

 b) 0.1 to 20% by weight of amphoteric surfactant (s).

applied to the hair and rinsed out after a contact time of 5 seconds to 5 minutes or is.

 This procedure according to the invention is based on a product according to the invention which is formulated as a so-called "rinse-off product", that is to say the product remains in the hair for a period of up to 5 minutes and is subsequently rinsed out Care products achieve or exceed those of conventional leave-in products.

 With regard to further preferred embodiments of the method according to the invention, mutatis mutandis the statements made concerning the agents according to the invention apply.

 Another object of the present invention is the use of mixtures of a) 3-methyl-1, 3-butanediol and

b) Amphotenaside (s). in hair cleansers.

With regard to further preferred embodiments of the use according to the invention, what has been said about the agents according to the invention applies mutatis mutandis.

Examples:

a. shampoo

 INCI name%

Sodium Laureth Sulfate 10.0

Cocoamidopropyl Betaine 3.0

Sodium Chloride 1, 0

PEG-7 Glyceryl Cocoate 1, 0

Citric Acid 1, 2

Polyquaternium-10 0.5

Sodium benzoate 0.5

Isopentyldiol 2.0

Hydrogenated Castor Oil 0.2

Salicylic Acid 0.2

Panthenol 2.0

Prunus Armeniaca (Apricot) Kernel Oil 0.5

Water ad 100 b. shampoo

 INCI name%

Sodium Laureth Sulfate 12.0

Cocoamidopropyl Betaine 5.0

Sodium Chloride 1, 0

Citric acid 0.5

Laureth-2 1, 0

PEG-12 dimethicone 1, 0

Sodium benzoate 0.5

PEG-7 Glyceryl Cocoate 0.5

Polyquaternium-10 0.6

Propylene glycol 0.5 PEG-55 Propylene Glycol Oleate 0.5

PEG-40 Hydrogenated Castor Oil 0.5

Isopentyldiol 5.0

Hydrolyzed Keratin 1, 0

Water ad 100 c. shampoo

 INCI name%

Sodium laureth-8 sulfates 10.0

Coco-Betaine 3.0

PEG-7 glyceryl cocoate 1, 5

Sodium Chloride 1, 0

Sodium PCA 1, 0

Citric Acid 1, 0

Polyquaternium-10 0.8

Sodium benzoate 0.5

Isopentyldiol 1, 0

Laureth-2 0.3

Salicylic Acid 0.3

PEG-55 Propylene Glycol Oleate 0.2

Propylene glycol 0.3

Laurdimonium Hydroxypropyl 0.5 Hydrolyzed Wheat Protein

 Benzophenone-4 0,5

Pantolactone 0.5

Water ad 100 d. shampoo

 INCI name%

Sodium C 14-18 olefin sulfonates 8.0 Coco-Glucoside 2.0

Disodiom ricinoleamido MEA-2.0 Sulfosuccinate

 Lauramidopropyl Betaine 2.0

Sodium Chloride 1, 0

Cocamidopropyl Betaine 2.0

Citric Acid 1, 0

Polyquaternium-10 0.8

Sodium benzoate 0.5

Isopentyldiol 1, 0

Laureth-2 0.3

Hydrogenated Castor Oil 0.2

Salicylic Acid 0.3

PEG-55 Propylene Glycol Oleate 0.2

Propylene glycol 0.3

Laurdimonium Hydroxypropyl 0.5 Hydrolyzed Wheat Protein

 Benzophenone-4 0,5

Pantolactone 0.5

Water ad 100

Claims

claims:

Hair treatment compositions containing - by weight - a) 0.01 to 40% by weight of 3-methyl-1, 3-butanediol,

 b) 0.1 to 20% by weight of amphoteric surfactant (s).

 Hair treatment composition according to claim 1, characterized in that it contains - based on its weight - 0.05 to 30 wt .-%, preferably 0, 1 to 20 wt .-% and in particular 0.25 to 10 wt .-% of 3-methyl Contains -1, 3-butanediol.

 Hair treatment composition according to one of claims 1 or 2, characterized in that, based on its weight, it contains from 0.1 to 15% by weight, preferably from 1 to 10% by weight and in particular from 2 to 8% by weight of amphoteric (cf. ) Surfactant (s) from the groups of

 N-alkyl,

 N-alkyl propionic acids,

 N-alkyl aminobutyric acids,

 N-alkyliminodipropionic,

 N-hydroxyethyl-N-alkylamido,

 N-alkyltaurines

 N-alkylsarcosines,

 2-Alkylaminopropionsäuren each having about 8 to 24 carbon atoms in the alkyl group,

Alkylaminoacetic acids each having about 8 to 24 carbon atoms in the alkyl group,

N-cocoalkyl,

 cocoacylaminoethylaminopropionate

 C-I2 - C-I8 - acylsarcosine,

 N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate,

 N-acylaminopropyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyl-dimethylammonium glycinate,

 2-Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group

 Kokosacy la minoethyl hyd roxyethy I carboxymethyl Ig lyci Nat

 the compounds known under the INCI name cocamidopropyl betaine.

 Hair treatment composition according to one of Claims 1 to 4, characterized in that, based on its weight, it contains from 0.1 to 15% by weight, preferably from 1 to 10% by weight, of the formula I

in which R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms.

Hair treatment composition according to one of Claims 1 to 4, characterized in that, based on its weight, it contains from 0.1 to 15% by weight, preferably from 1 to 10% by weight and in particular from 2 to 8% by weight of betaines (e ) of the formula

in which R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms.

Hair treatment composition according to one of Claims 1 to 5, characterized in that it contains, based on its weight, from 0.05 to 7.5% by weight, preferably from 0.1 to 5% by weight, more preferably from 0.2 to 3 , 5 wt .-% and in particular 0.25 to 2.5 wt .-% cationic (s) polymer (s) from the group

 Poly (methacryloyloxyethyltrimethylammonium chloride) (INCI: Polyquaternium-37) and / or;

 quaternized cellulose derivatives, in particular Polyquaternium 10 and / or Polyquaternium 67, and / or

 cationic alkyl polyglycosides and / or

 cationised honey and / or

 cationic guar derivatives and / or

 polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of acrylic acid and methacrylic acid and / or

 Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate and / or

 Vinylpyrrolidone-Vinylimidazoliummethochlorid copolymers and / or quaternized polyvinyl alcohol and / or

 Polyquaternium 2 and / or

 Polyquaternium-7 and / or

 Polyquaternium-16 and / or

 Polyquaternium 17 and / or

 Polyquaternium 18 and / or

 Polyquaternium 24 and / or

 Polyquaternium 27 and / or

 Polyquaternium 74

contains.

7. hair treatment composition according to any one of claims 1 to 6, characterized in that it - based on its weight - 0, 1 to 10 wt .-%, preferably 0.25 to 7 wt .-% and in particular 0.5 to 5 wt % Silicone (s) of the formula Si-I

(CH ₃ ) ₃ Si [0-Si (CH ₃ ) 2] x-0-Si (CH ₃ ) 3 (Si-I),

 in which x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and in particular 0 to 10, stands.

 8. hair treatment composition according to any one of claims 1 to 7, characterized in that it - based on its weight - 0, 1 to 10 wt .-%, preferably 0.25 to 7 wt .-% and in particular 0.5 to 5 wt .-% silicone (s) of the formula Si-lia and / or Si-Ilb

(CH ₃ ) ₃ Si [0-Si (CH ₃ ) ₂ ] _n [OSi (CH ₃ )] _m -OSi (CH ₃ ) ₃ (Si-Ila),

 I

CH ₂ CH (CH 3) CH ₂ NH (CH ₂ ) ₂ NH ₂

R- [Si (CH _{3) 2} -0] _n1 [Si (R) -0] _k - [Si (CH _{3) 2]} n2-R (Si-IIb),

 I

 contains in which

 om and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n is preferably values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10

o R is -OH, -O-CH ₃ or a -CH ₃ group

 ok, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2000, preferably between 50 and 150, the sum (n1 + n2) preferably being values from 0 to 1999 and in particular from 49 to 149 and m preferably assumes values of from 1 to 2000, in particular from 1 to 10.

 9. A process for the purification of keratinic fibers, characterized in that a hair treatment composition containing - based on its weight - a) 0.01 to 40 wt .-% of 3-methyl-1, 3-butanediol,

 b) 0.1 to 20% by weight of amphoteric surfactant (s).

 applied to the hair and rinsed out after a contact time of 5 seconds to 5 minutes or is.

 10. Use of mixtures

 a) 3-methyl-1,3-butanediol and

 b) Amphoteric surfactant (s).

 in hair cleansers.